G Squared Ascend II Will Redeem Public Shares

G Squared Ascend II Will Redeem Public Shares

NEW YORK–(BUSINESS WIRE)–
G Squared Ascend II Inc. (the “Company”) (NYSE: GSQB.U, GSQB, GSQB.W), a special purpose acquisition company, today announced that it will redeem all of its outstanding Class A ordinary shares, par value $0.0001 per share (the “Public Shares”), effective as of the close of business on June 16, 2023, because the Company will not consummate an initial business combination within the time period required by its Amended and Restated Memorandum and Articles of Association (the “Articles”).

As such, in accordance with the Company’s Articles, the Company will:

  • cease all operations as of June 16, 2023, except for the purpose of winding up;

  • as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Company’s trust account (the “Trust Account”), including interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company’s income taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the Public Shares then in issue, which redemption will completely extinguish public Members’ (as defined in the Articles) rights as Members of the Company (including the right to receive further liquidation distributions, if any); and

  • as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Members and the Company’s board of directors, liquidate and dissolve,

subject in each case, to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

The per-share redemption price for the public shares will be approximately $10.44, excluding any permitted deductions (the “Redemption Amount”). The balance of the Trust Account as of June 6, 2023 was approximately $150,211,042, which includes approximately $5,023,542 in interest and dividend income (excess of cash over $ 145,187,500, the funds deposited into the Trust Account). In accordance with the terms of the related trust agreement, the Company expects to retain up to $100,000 of the interest and dividend income from the Trust Account to pay dissolution expenses.

The last day of trading will be June 16, 2023.

As of the close of business on June 16, 2023, the Public Shares will be deemed cancelled and will represent only the right to receive the Redemption Amount.

The Redemption Amount will be payable to the holders of the Public Shares upon presentation of their respective stock or unit certificates or other delivery of their shares or units to the Company’s transfer agent, Continental Stock Transfer & Trust Company. Beneficial owners of public shares held in “street name,” however, will not need to take any action in order to receive the Redemption Amount.

There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless.

The Company’s sponsor has waived its redemption rights with respect to the outstanding Class B ordinary shares held by the sponsor. After June 16, 2023, the Company shall cease all operations except for those required to wind up the Company’s business.

The Company expects that the New York Stock Exchange will file a Form 25 with the U.S. Securities and Exchange Commission (the “Commission”) to delist its securities. The Company thereafter expects to file a Form 15 with the Commission to terminate the registration of its securities under the Securities Exchange Act of 1934, as amended.

Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. When used in this press release, the words “could,” “should,” “will,” “may,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “project,” the negative of such terms and other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. Such forward-looking statements are based on current information and expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing the Company’s views as of any subsequent date, and the Company does not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. You should not place undue reliance on these forward-looking statements. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the “Risk Factors” in the Company’s registration statement on Form S-1 (Registration No. 333-252268), as amended, initially filed with the Commission on January 20, 2021, relating to its initial public offering, annual, quarterly reports and subsequent reports filed with the Commission, as amended from time to time. Copies of such filings are available on the Commission’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Company:

G Squared Ascend II, Inc.

205 N Michigan Ave, Suite 3770

Chicago, IL

(313) 552-7160

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Steel Connect Reports Third Quarter Fiscal 2023 Financial Results

Steel Connect Reports Third Quarter Fiscal 2023 Financial Results

Third Quarter 2023 Results

  • Net revenue from continuing operations totaled $46.1 million, as compared to $51.5 million in the same period in the prior year.

  • Net income from continuing operations was $3.0 million, as compared to net loss from continuing operations of $9.7 million in the same period in the prior year.

  • Net income attributable to common stockholders was $2.5 million, as compared to net income attributable to common stockholders of $29.7 million in the same period in the prior year.

  • Adjusted EBITDA* was $5.2 million, as compared to $0.9 million in the same period in the prior year.

  • Net cash used in operating activities was $0.6 million.

  • Free Cash Flow* totaled $(1.0) million.

  • Total debt, net of unamortized discounts and issuance costs, was $11.5 million; Net Debt* totaled $(48.8) million.

Nine-Month Fiscal Year-to-Date Financial Results

  • Net revenue from continuing operations totaled $148.3 million, as compared to $150.2 million in the same period in the prior year.

  • Net income from continuing operations was $7.5 million, as compared to net loss from continuing operations of $12.2 million in the same period in the prior year.

  • Net income attributable to common stockholders was $5.9 million, as compared to net loss attributable to common stockholders of $13.9 million in the same period in the prior year.

  • Adjusted EBITDA* was $17.1 million, as compared to $3.3 million in the same period in the prior year.

  • Net cash provided by operating activities was $9.0 million.

  • Free Cash Flow* totaled $7.7 million.

Other Developments

  • On May 1, 2023, Steel Connect, Inc. and Steel Partners Holdings L.P (“Steel Partners”), completed an exchange transaction in which Steel Partners and certain of its affiliates transferred certain marketable securities to Steel Connect, Inc. in exchange for 3.5 million shares of Series E Convertible Preferred Stock of Steel Connect.

NEW YORK–(BUSINESS WIRE)–
Steel Connect, Inc. (the “Company”) (NASDAQ: STCN) today announced financial results for its third quarter ended April 30, 2023.

Recent Developments

On May 1, 2023, the Company and Steel Partners transferred certain marketable securities held by Steel Partners and certain of its affiliates to the Company in exchange for 3.5 million shares of Series E Convertible Preferred Stock of Steel Connect (the “Exchange Transaction”). Following recent approval by the Steel Connect stockholders pursuant to NASDAQ Marketplace Rules, the Series E Convertible Preferred Stock is convertible into an aggregate of 184.9 million shares of Steel Connect common stock, par value $0.01 per share, and will vote together with the Steel Connect common stock and participate in any dividends paid on the Steel Connect common stock, in each case on an as-converted basis. Upon conversion of the Series E Convertible Preferred Stock, the Steel Partners Group would hold approximately 85% of the outstanding equity interests of Steel Connect.

The Exchange Transaction will be accounted for as of May 1, 2023, which is the date the consideration was exchanged between the Company and Steel Partners.

Results of Operations

The financial information and discussion that follows below are for the Company’s operations.

 

 

Three Months Ended

April 30

 

Nine Months Ended

April 30,

 

 

2023

 

2022

 

2023

 

2022

 

 

(in thousands)

Net revenue

 

$

46,142

 

 

$

51,548

 

 

$

148,283

 

 

$

150,223

 

Net income (loss) from continuing operations

 

 

3,029

 

 

 

(9,695

)

 

 

7,460

 

 

 

(12,163

)

Net income (loss) attributable to common stockholders

 

$

2,510

 

 

$

29,663

 

 

$

5,867

 

 

$

(13,882

)

Adjusted EBITDA*

 

$

5,233

 

 

$

938

 

 

$

17,145

 

 

$

3,318

 

Adjusted EBITDA margin*

 

 

11.3

%

 

 

1.8

%

 

 

11.6

%

 

 

2.2

%

Net cash (used in) provided by operating activities

 

 

(588

)

 

 

(2,544

)

 

 

9,000

 

 

 

(5,267

)

Additions to property and equipment

 

 

(445

)

 

 

(316

)

 

 

(1,311

)

 

 

(1,142

)

Free cash flow*

 

$

(1,033

)

 

$

(2,860

)

 

$

7,689

 

 

$

(6,409

)

* See reconciliations of these non-GAAP measurements to the most directly comparable GAAP measures included in the financial tables. See also “Note Regarding Use of Non-GAAP Financial Measurements” below for the definitions of these non-GAAP measures.

Results of Operations

Comparison of the Third Quarter and Nine Months Ended April 30, 2023 and 2022

 

Three Months Ended

April 30,

 

Nine Months Ended

April 30,

 

2023

 

2022

 

Fav (Unfav) ($)

 

2023

 

2022

 

Fav (Unfav) ($)

 

(unaudited, $ in thousands)

 

 

 

(unaudited, $ in thousands)

 

 

Net revenue

$

46,142

 

 

$

51,548

 

 

 

(5,406

)

 

$

148,283

 

 

$

150,223

 

 

 

(1,940

)

Cost of revenue

 

(33,218

)

 

 

(42,303

)

 

 

9,085

 

 

 

(108,031

)

 

 

(120,672

)

 

 

12,641

 

Gross profit

 

12,924

 

 

 

9,245

 

 

 

3,679

 

 

 

40,252

 

 

 

29,551

 

 

 

10,701

 

Gross profit margin

 

28.0

%

 

 

17.9

%

 

1010 bpts

 

 

27.1

%

 

 

19.7

%

 

740 bpts

Selling, general and administrative

 

(12,619

)

 

 

(9,214

)

 

 

(3,405

)

 

 

(33,463

)

 

 

(28,899

)

 

 

(4,564

)

Interest expense

 

(914

)

 

 

(848

)

 

 

(66

)

 

 

(2,588

)

 

 

(2,359

)

 

 

(229

)

Other gains, net

 

4,489

 

 

 

2,154

 

 

 

2,335

 

 

 

4,889

 

 

 

1,614

 

 

 

3,275

 

Total costs and expenses

 

(9,044

)

 

 

(7,908

)

 

 

(1,136

)

 

 

(31,162

)

 

 

(29,644

)

 

 

(1,518

)

Income (loss) from continuing operations before income taxes

 

3,880

 

 

 

1,337

 

 

 

2,543

 

 

 

9,090

 

 

 

(93

)

 

 

9,183

 

Income tax expense

 

(851

)

 

 

(11,032

)

 

 

10,181

 

 

 

(1,630

)

 

 

(12,070

)

 

 

10,440

 

Net income (loss) from continuing operations

$

3,029

 

 

$

(9,695

)

 

$

12,724

 

 

$

7,460

 

 

$

(12,163

)

 

$

19,623

 

Net Revenue

During the three months ended April 30, 2023, net revenue decreased by approximately $5.4 million. The decrease in net revenue during the three months ended April 30, 2023 as compared to the same period in the prior year was primarily driven by $4.6 million lower net revenue associated with certain clients in the computing and consumer electronics markets and the medical devices electronics markets due to lower demand, and loss of certain programs, partially offset by new business revenue.

During the nine months ended April 30, 2023, net revenue decreased by approximately $1.9 million as compared to the same period in the prior year. This decrease in net revenue was driven by overall lower volumes associated with clients in the computing and consumer electronics markets as compared to the same period in the prior year. Fluctuations in foreign currency exchange rates had an insignificant impact on the Company’s net revenues for the three and nine month periods ended April 30, 2023 and 2022, respectively.

Cost of Revenue

Total cost of revenue decreased by $9.1 million for the three months ended April 30, 2023, as compared to the same period in the prior year, primarily driven by a decrease in cost of materials as a result of the decrease in the amount of materials procured on behalf of Supply Chain clients. Cost of revenue for the three months ended April 30, 2023 included materials procured on behalf of our Supply Chain clients of $16.2 million, as compared to $24.3 million for the same period in the prior year, a decrease of $8.1 million. The remaining $1.0 million decrease is driven by lower labor costs, such as a decrease in salaries and wages and production costs, and a decrease in buildings and facilities costs.

Cost of revenue decreased by $12.6 million for the nine months ended April 30, 2023, as compared to the same period in the prior year, driven by the decrease in cost of materials as a result of the decrease in net revenue discussed above. Cost of revenue for the nine months ended April 30, 2023 included materials procured on behalf of our Supply Chain clients of $56.6 million, as compared to $69.1 million for the same period in the prior year, a decrease of $12.5 million, driven by overall lower volumes and lower costs on programs launched in the prior year period along with lower material costs related to programs that ended during the current year period. Fluctuations in foreign currency exchange rates had an insignificant impact on the Company’s cost of revenue for the three and nine month periods ended April 30, 2023 and 2022, respectively.

Gross Profit Margin

Gross profit percentage for the current quarter increased 1,010 basis points, to 28.0% as compared to 17.9% in the prior year quarter, driven largely by changes in customer sales mix and the decrease in cost of revenue discussed above.

Gross profit percentage for the nine months ended April 30, 2023 increased 740 basis points, to 27.1% as compared to 19.7% for the nine months ended April 30, 2022, driven largely by changes in customer sales mix and the decrease in cost of revenue discussed above. Fluctuations in foreign currency exchange rates had an insignificant impact on Supply Chain’s gross margin for the three and nine month periods ended April 30, 2023 and 2022, respectively.

Selling, General and Administrative

Selling, general and administrative expenses (“SG&A”) during the three months ended April 30, 2023 increased by approximately $3.4 million as compared to the same period in the prior year primarily due to higher professional and legal fees for Corporate related to the exchange transaction with Steel Partners Holdings L.P. (“Steel Holdings”). SG&A expenses during the three months ended April 30, 2023 for the Supply Chain segment did not change significantly as compared to the same period in the prior year.

SG&A expenses during the nine months ended April 30, 2023 increased by approximately $4.6 million as compared to the same period in the prior year. Corporate-level activity increased $4.5 million primarily due to higher professional and legal fees related to the Exchange Transaction with Steel Holdings. SG&A expenses during the nine months ended April 30, 2023 for the Supply Chain segment did not change significantly as compared to the same period in the prior year. Fluctuations in foreign currency exchange rates did not have a significant impact on selling, general and administrative expenses for the three and nine months ended April 30, 2023, 2022, respectively.

Interest Expense

Total interest expense increased by $0.1 million and $0.2 million during the three and nine months ended April 30, 2023, respectively, as compared to the same periods in the prior year, primarily due to higher interest expense related to accretion of the discount on the 7.50% convertible senior note with Steel Holdings.

Other Gains, Net

During the three months ended April 30, 2023 and 2022, the Company recorded Other gains, net of $4.5 million and $2.2 million, respectively.

Other gains, net for the three months ended April 30, 2023 was primarily due to: (1) $1.9 million gain from proceeds received from the sale of an investment in Tallan, Inc., (2) $1.4 million settlement with a client; (3) $0.5 million interest income; and (4) $0.3 million foreign exchange gains. Other gains, net for the three months ended April 30, 2022 was primarily due to foreign exchange gains.

During the nine months ended April 30, 2023 and 2022, the Company recorded Other gains, net of $4.9 million and $1.6 million, respectively.

Other gains, net for the nine months ended April 30, 2023 was primarily due to: (1) $1.9 million gain from proceeds received from the sale of an investment in Tallan, Inc., (2) $1.4 million settlement with a client, (3) $0.9 million interest income; and (4) $0.8 million sublease income. These gains were partially offset by $0.5 million foreign exchange losses. Other gains, net for the nine months ended April 30, 2022 was primarily due to $1.0 million foreign exchange gains, and $0.5 million sublease income.

Income Tax Expense

During the three months ended April 30, 2023, the Company recorded income tax expense of approximately $0.9 million as compared to $11.0 million in income tax expense for the same period in the prior fiscal year. The decrease in income tax expense is primarily due to the tax effect of the IWCO disposal during the three months ended April 30, 2022.

During the nine months ended April 30, 2023, the Company recorded income tax expense of approximately $1.6 million as compared to $12.1 million for the same period in the prior fiscal year. The decrease in income tax expense is primarily due to the tax effect of the IWCO disposal during the nine months ended April 30, 2022.

Net Income (Loss) From Continuing Operations

Net income from continuing operations for the three months ended April 30, 2023 increased $12.7 million as compared to the same period in the prior fiscal year, driven by the $10.2 million favorable change in income taxes. Refer to discussion above for further details.

Net income (loss) from continuing operations for the nine months ended April 30, 2023 increased $19.6 million, as compared to the same period in the prior year. The increase in net income from continuing operations is primarily due to the increase in gross profit and a decrease in income tax expense. Refer to explanations above for further details regarding specific increases or decreases.

Additions to Property and Equipment (Capital Expenditures)

Capital expenditures for the third quarter totaled $0.4 million, or 1.0% of net revenue, as compared to $0.3 million, or 0.6% of net revenue, for the same period in the prior year.

Capital expenditures for the nine months ended April 30, 2023 totaled $1.3 million, or 0.9% of net revenue, as compared to $1.1 million, or 0.8% of net revenue, for the same period in the prior year.

Adjusted EBITDA

Adjusted EBITDA increased $4.3 million, or 457.9%, for the third quarter as compared to the same period in the prior year, primarily due to an increase in net income from continuing operations of $12.7 million, along with increases in adjustments for strategic consulting and other related professional fees of $3.6 million and unrealized foreign exchange gains of $2.0 million, offset by decreases in adjustments related to income tax expense of $10.2 million and other non-cash gains of $3.3 million.

Adjusted EBITDA increased $13.8 million, or 416.7%, for the nine months ended April 30, 2023 as compared to the same period in the prior year. The increase is primarily due to an increase in net income from continuing operations of $19.6 million, along with increases in adjustments of $6.5 million change from unrealized foreign exchange gains to unrealized foreign exchange losses and $4.1 million in strategic consulting and other related professional fees, offset by decreases in adjustments related to (i) income tax expense of $10.4 million; (ii) other non-cash gains of $3.4 million; (iii) restructuring and executive severance and employee retention costs of $1.4 million; and (iv) interest income of $0.9 million.

Liquidity and Capital Resources

As of April 30, 2023, the Company had cash and cash equivalents of $62.7 million and ModusLink had readily available borrowing capacity of $11.9 million under its revolving credit facility with Umpqua Bank.

As of April 30 2023, total debt outstanding, net of unamortized discounts and issuance costs, was $11.5 million, which was comprised of $13.9 million outstanding on the 7.50% Convertible Senior Note due September 1, 2024, less associated unamortized discounts and issuance costs, as well as unamortized deferred financing costs on the Umpqua Revolver.

About Steel Connect, Inc.

Steel Connect, Inc. is a holding company whose wholly-owned subsidiary, ModusLink Corporation, serves the supply chain management market.

ModusLink is an end-to-end global supply chain solutions and e-commerce provider serving clients in markets such as consumer electronics, communications, computing, medical devices, software and retail. ModusLink designs and executes critical elements in its clients’ global supply chains to improve speed to market, product customization, flexibility, cost, quality and service. These benefits are delivered through a combination of industry expertise, innovative service solutions, and integrated operations, proven business processes, an expansive global footprint and world-class technology. ModusLink also produces and licenses an entitlement management solution powered by its enterprise-class Poetic software, which offers a complete solution for activation, provisioning, entitlement subscription, and data collection from physical goods (connected products) and digital products. ModusLink has an integrated network of strategically located facilities in various countries, including numerous sites throughout North America, Europe and Asia.

– Financial Tables Follow –

 

 

Steel Connect, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(in thousands)

 

 

April 30, 2023

 

July 31, 2022

 

(unaudited)

 

 

ASSETS

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

62,738

 

 

$

53,142

 

Accounts receivable, trade, net

 

36,948

 

 

 

40,083

 

Inventories, net

 

6,919

 

 

 

8,151

 

Funds held for clients

 

3,158

 

 

 

4,903

 

Prepaid expenses and other current assets

 

4,985

 

 

 

3,551

 

Total current assets

 

114,748

 

 

 

109,830

 

Property and equipment, net

 

3,401

 

 

 

3,534

 

Operating lease right-of-use assets

 

28,892

 

 

 

19,655

 

Other assets

 

3,899

 

 

 

4,730

 

Total assets

$

150,940

 

 

$

137,749

 

 

 

 

 

LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

26,290

 

 

$

30,553

 

Accrued expenses

 

29,154

 

 

 

28,396

 

Funds held for clients

 

3,064

 

 

 

4,903

 

Current lease obligations

 

7,994

 

 

 

6,466

 

Other current liabilities

 

13,760

 

 

 

13,482

 

Total current liabilities

 

80,262

 

 

 

83,800

 

Convertible note payable

 

11,586

 

 

 

11,047

 

Long-term lease obligations

 

21,260

 

 

 

12,945

 

Other long-term liabilities

 

5,546

 

 

 

3,983

 

Total long-term liabilities

 

38,392

 

 

 

27,975

 

Total liabilities

 

118,654

 

 

 

111,775

 

 

 

 

 

Series C redeemable preferred stock, $0.01 par value per share. 35,000 shares authorized, issued and outstanding at April 30, 2023 and July 31, 2022

 

35,175

 

 

 

35,180

 

 

 

 

 

Series C convertible preferred stock, $0.01 par value per share. 4,965,000 shares authorized at April 30, 2023 and July 31, 2022; zero shares issued and outstanding at April 30, 2023 and July 31, 2022

 

 

 

 

 

Common stock, $0.01 par value per share. Authorized 1,400,000,000 shares; 60,942,460 issued and outstanding shares at April 30, 2023; 60,529,558 issued and outstanding shares at July 31, 2022

 

609

 

 

 

605

 

Additional paid-in capital

 

7,479,891

 

 

 

7,479,366

 

Accumulated deficit

 

(7,487,450

)

 

 

(7,493,317

)

Accumulated other comprehensive income

 

4,061

 

 

 

4,140

 

Total stockholders’ deficit

 

(2,889

)

 

 

(9,206

)

 

 

 

 

Total liabilities, redeemable preferred stock and stockholders’ deficit

$

150,940

 

 

$

137,749

 

 

Steel Connect, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

(in thousands, except per share amounts)

(unaudited)

 

 

Three Months Ended

April 30,

 

Nine Months Ended

April 30,

 

2023

 

2022

 

2023

 

2022

Net revenue

$

46,142

 

 

$

51,548

 

 

$

148,283

 

 

$

150,223

 

Cost of revenue

 

33,218

 

 

 

42,303

 

 

 

108,031

 

 

 

120,672

 

Gross profit

 

12,924

 

 

 

9,245

 

 

 

40,252

 

 

 

29,551

 

Operating expenses:

 

 

 

 

 

 

 

Selling, general and administrative

 

12,619

 

 

 

9,214

 

 

 

33,463

 

 

 

28,899

 

Total operating expenses

 

12,619

 

 

 

9,214

 

 

 

33,463

 

 

 

28,899

 

Operating income

 

305

 

 

 

31

 

 

 

6,789

 

 

 

652

 

Other income (expense):

 

 

 

 

 

 

 

Interest income

 

452

 

 

 

3

 

 

 

928

 

 

 

9

 

Interest expense

 

(914

)

 

 

(848

)

 

 

(2,588

)

 

 

(2,359

)

Other gains, net

 

4,037

 

 

 

2,151

 

 

 

3,961

 

 

 

1,605

 

Total other income (expense)

 

3,575

 

 

 

1,306

 

 

 

2,301

 

 

 

(745

)

Income (loss) from continuing operations before income taxes

 

3,880

 

 

 

1,337

 

 

 

9,090

 

 

 

(93

)

Income tax expense

 

851

 

 

 

11,032

 

 

 

1,630

 

 

 

12,070

 

Net income (loss) from continuing operations

 

3,029

 

 

 

(9,695

)

 

 

7,460

 

 

 

(12,163

)

Net income (loss) from discontinued operations

 

 

 

 

39,895

 

 

 

 

 

 

(108

)

Net income (loss)

 

3,029

 

 

 

30,200

 

 

 

7,460

 

 

 

(12,271

)

Less: Preferred dividends on Series C redeemable preferred stock

 

(519

)

 

 

(537

)

 

 

(1,593

)

 

 

(1,611

)

Net income (loss) attributable to common stockholders

$

2,510

 

 

$

29,663

 

 

$

5,867

 

 

$

(13,882

)

 

 

 

 

 

 

 

 

Net income (loss) per common shares – basic

 

 

 

 

 

 

 

Continuing operations

$

0.04

 

 

$

(0.17

)

 

$

0.10

 

 

$

(0.23

)

Discontinued operations

 

 

 

 

0.67

 

 

 

 

 

 

 

Net (loss) income attributable to common stockholders

$

0.04

 

 

$

0.50

 

 

$

0.10

 

 

$

(0.23

)

 

 

 

 

 

 

 

 

Net income (loss) per common shares – diluted

 

 

 

 

 

 

 

Continuing operations

$

0.04

 

 

$

(0.17

)

 

$

0.09

 

 

$

(0.23

)

Discontinued operations

 

 

 

 

0.67

 

 

 

 

 

 

 

Net (loss) income attributable to common stockholders

$

0.04

 

 

$

0.50

 

 

$

0.09

 

 

$

(0.23

)

 

 

 

 

 

 

 

 

Weighted-average number of common shares outstanding – basic

 

60,305

 

 

 

59,853

 

 

 

60,186

 

 

 

59,961

 

Weighted-average number of common shares outstanding – diluted

 

78,695

 

 

 

59,853

 

 

 

78,559

 

 

 

59,961

 

 

 

Steel Connect, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

 

 

Nine months ended April 30,

 

2023

 

2022

Cash flows from operating activities:

 

 

 

Net income (loss)

$

7,460

 

 

$

(12,271

)

Less: Loss from discontinued operations, net of tax

 

 

 

 

108

 

Income (loss) from continuing operations

 

7,460

 

 

 

(12,163

)

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

 

 

 

Depreciation

 

1,427

 

 

 

1,698

 

Amortization of deferred financing costs

 

36

 

 

 

102

 

Accretion of debt discount

 

1,510

 

 

 

1,229

 

Share-based compensation

 

529

 

 

 

519

 

Non-cash lease expense

 

6,760

 

 

 

7,083

 

Bad debt expense (recovery)

 

1,136

 

 

 

(3

)

Other losses, net

 

(3,962

)

 

 

(1,605

)

Changes in operating assets and liabilities:

 

 

 

Accounts receivable, net

 

2,933

 

 

 

(8,783

)

Inventories, net

 

1,440

 

 

 

(1,291

)

Prepaid expenses and other current assets

 

(1,237

)

 

 

240

 

Accounts payable and accrued expenses

 

(3,886

)

 

 

2,076

 

Refundable and accrued income taxes, net

 

(829

)

 

 

142

 

Other assets and liabilities

 

(4,317

)

 

 

5,489

 

Net cash provided by (used in) operating activities

 

9,000

 

 

 

(5,267

)

Cash flows from investing activities:

 

 

 

Additions to property and equipment

 

(1,311

)

 

 

(1,142

)

Proceeds from the disposition of property and equipment

 

166

 

 

 

 

Proceeds from sale of investment

 

1,881

 

 

 

 

Net cash provided by (used in) investing activities

 

736

 

 

 

(1,142

)

Cash flows from financing activities:

 

 

 

Series C redeemable preferred stock dividend payments

 

(1,593

)

 

 

(1,598

)

Repayments on capital lease obligations

 

(38

)

 

 

(54

)

Repayments on convertible debt

 

(1,149

)

 

 

 

Net cash used in financing activities

 

(2,780

)

 

 

(1,652

)

Net effect of exchange rate changes on cash and cash equivalents

 

895

 

 

 

(774

)

Net increase in cash, cash equivalents and restricted cash

 

7,851

 

 

 

(8,835

)

Cash, cash equivalents and restricted cash, beginning of period

 

58,045

 

 

 

66,329

 

Cash, cash equivalents and restricted cash, end of period

$

65,896

 

 

$

57,494

 

 

 

 

 

Cash and cash equivalents, end of period

$

62,738

 

 

$

49,914

 

Restricted cash for funds held for clients, end of period

 

3,158

 

 

 

7,580

 

Cash, cash equivalents and restricted cash, end of period

$

65,896

 

 

$

57,494

 

 

 

 

 

Cash flows from discontinued operations:

 

 

 

Operating activities

$

 

 

$

(6,738

)

Investing activities

 

 

 

 

625

 

Financing activities

 

 

 

 

4,230

 

Net cash used in discontinued operations

$

 

 

$

(1,883

)

 

Steel Connect, Inc. and Subsidiaries

Segment Data

(in thousands)

(unaudited)

 

 

Three Months Ended

April 30,

 

Nine Months Ended

April 30,

 

2023

 

2022

 

2023

 

2022

 

(Unaudited)

 

 

 

 

Net revenue:

 

 

 

 

 

 

 

Supply Chain

$

46,142

 

 

$

51,548

 

 

$

148,283

 

 

$

150,223

 

 

 

46,142

 

 

 

51,548

 

 

 

148,283

 

 

 

150,223

 

Operating income:

 

 

 

 

 

 

 

Supply Chain

 

5,249

 

 

 

1,548

 

 

 

16,488

 

 

 

5,894

 

Total segment operating income

 

5,249

 

 

 

1,548

 

 

 

16,488

 

 

 

5,894

 

Corporate-level activity

 

(4,944

)

 

 

(1,517

)

 

 

(9,699

)

 

 

(5,242

)

Total operating income

 

305

 

 

 

31

 

 

 

6,789

 

 

 

652

 

Total other income (expense), net

 

3,575

 

 

 

1,306

 

 

 

2,301

 

 

 

(745

)

Income (loss) before income taxes

$

3,880

 

 

$

1,337

 

 

$

9,090

 

 

$

(93

)

 

Steel Connect, Inc. and Subsidiaries

Reconciliation of Non-GAAP Measures to GAAP Measures

(in thousands)

(unaudited)

 
 

EBITDA and Adjusted EBITDA Reconciliations:

 

 

Three Months Ended

April 30,

 

Nine Months Ended

April 30,

 

2023

 

2022

 

2023

 

2022

Net income (loss) from continuing operations

$

3,029

 

 

$

(9,695

)

 

$

7,460

 

 

$

(12,163

)

 

 

 

 

 

 

 

 

Interest income

 

(452

)

 

 

(3

)

 

 

(928

)

 

 

(9

)

Interest expense

 

914

 

 

 

848

 

 

 

2,588

 

 

 

2,359

 

Income tax expense

 

851

 

 

 

11,032

 

 

 

1,630

 

 

 

12,070

 

Depreciation

 

502

 

 

 

523

 

 

 

1,427

 

 

 

1,698

 

EBITDA

 

4,844

 

 

 

2,705

 

 

 

12,177

 

 

 

3,955

 

 

 

 

 

 

 

 

 

Strategic consulting and other related professional fees

 

3,786

 

 

 

163

 

 

 

4,617

 

 

 

509

 

Executive severance and employee retention

 

 

 

 

58

 

 

 

(150

)

 

 

414

 

Restructuring and restructuring-related expense

 

97

 

 

 

118

 

 

 

97

 

 

 

974

 

Share-based compensation

 

174

 

 

 

111

 

 

 

529

 

 

 

519

 

(Gain) loss on sale of long-lived assets

 

(145

)

 

 

2

 

 

 

(129

)

 

 

3

 

Unrealized foreign exchange (gains) losses, net

 

(167

)

 

 

(2,127

)

 

 

3,561

 

 

 

(2,931

)

Other non-cash gains, net

 

(3,356

)

 

 

(92

)

 

 

(3,557

)

 

 

(125

)

Adjusted EBITDA

$

5,233

 

 

$

938

 

 

$

17,145

 

 

$

3,318

 

 

 

 

 

 

 

 

 

Net revenue

$

46,142

 

 

$

51,548

 

 

$

148,283

 

 

$

150,223

 

Adjusted EBITDA margin

 

11.3

%

 

 

1.8

%

 

 

11.6

%

 

 

2.2

%

Free Cash Flow Reconciliation:

 
 

 

Three Months Ended

April 30,

 

Nine Months Ended

April 30,

 

2023

 

2022

 

2023

 

2022

Net cash (used in) provided by operating activities

$

(588

)

 

$

(2,544

)

 

$

9,000

 

 

$

(5,267

)

Additions to property and equipment

 

(445

)

 

 

(316

)

 

 

(1,311

)

 

 

(1,142

)

Free cash flow

$

(1,033

)

 

$

(2,860

)

 

$

7,689

 

 

$

(6,409

)

 

 

 

 

 

 

 

 

Net Debt Reconciliation:

 

 

April 30,

2023

 

July 31,

2022

Total debt, net

$

11,543

 

 

$

10,968

 

Unamortized discounts and issuance costs

 

2,397

 

 

 

3,972

 

Cash and cash equivalents

 

(62,738

)

 

 

(53,142

)

Net debt

$

(48,798

)

 

$

(38,202

)

Note Regarding Use of Non-GAAP Financial Measurements

In addition to the financial measures prepared in accordance with generally accepted accounting principles, the Company uses EBITDA, Adjusted EBITDA, Free Cash Flow and Net Debt, all of which are non-GAAP financial measures, to assess its performance. EBITDA represents earnings from continuing operations before interest income, interest expense, income tax (benefit) expense, and depreciation. We define Adjusted EBITDA as net income (loss) from continuing operations excluding net charges related to interest income, interest expense, income tax expense, depreciation, strategic consulting and other related professional fees, executive severance and employee retention, restructuring and restructuring-related expense, share-based compensation, (gain) loss on sale of long-lived assets, unrealized foreign exchange (gains) losses, net, and other non-cash gains, net. The Company defines Free Cash Flow as net cash (used in) provided by operating activities less additions to property and equipment, and defines Net Debt as the sum of total debt, excluding reductions for unamortized discounts and issuance costs, less cash and cash equivalents.

We believe that providing these non-GAAP measurements to investors is useful, as these measures provide important supplemental information of our performance to investors and permit investors and management to evaluate the operating performance of our business. These measures provide useful supplemental information to management and investors regarding our operating results as they exclude certain items whose fluctuation from period-to-period do not necessarily correspond to changes in the operating results of our business. We use EBITDA and Adjusted EBITDA in internal forecasts and models when establishing internal operating budgets, supplementing the financial results and forecasts reported to our Board of Directors, determining a component of certain incentive compensation for executive officers and other key employees based on operating performance, determining compliance with certain covenants in the Company’s credit facilities, and evaluating short-term and long-term operating trends in our core business. We use Free Cash Flow to conduct and evaluate our business because, although it is similar to cash flow from operations, we believe it is a useful measure of cash flows since purchases of property and equipment are a necessary component of ongoing operations, and similar to the use of Net Debt, assists management with its capital planning and financing considerations.

We believe that these non-GAAP financial measures assist in providing an enhanced understanding of our underlying operational measures to manage our core businesses, to evaluate performance compared to prior periods and the marketplace, and to establish operational goals. Further, we believe that these non-GAAP financial adjustments are useful to investors because they allow investors to evaluate the effectiveness of the methodology and information used by management in our financial and operational decision-making. These non-GAAP financial measures should not be considered in isolation or as a substitute for financial information provided in accordance with U.S. GAAP. These non-GAAP financial measures may not be computed in the same manner as similarly titled measures used by other companies

Some of the limitations of EBITDA and Adjusted EBITDA include:

  • EBITDA and Adjusted EBITDA do not reflect changes in, or cash requirements for, our working capital needs;

  • EBITDA and Adjusted EBITDA do not reflect our interest expense, or the cash requirements necessary to service interest or principal payments, on our debt;

  • EBITDA and Adjusted EBITDA do not reflect our tax expense or the cash requirements to pay our taxes;

  • EBITDA and Adjusted EBITDA do not reflect historical capital expenditures or future requirements for capital expenditures or contractual commitments;

  • although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and EBITDA and Adjusted EBITDA do not reflect any cash requirements for such replacements; and

  • other companies in our industry may calculate EBITDA and Adjusted EBITDA differently, limiting their usefulness as comparative measures.

In addition, Net Debt assumes the Company’s cash and cash equivalents can be used to reduce outstanding debt without restriction, while Free Cash Flow has limitations due to the fact that it does not represent the residual cash flow available for discretionary expenditures and excludes the Company’s remaining investing activities and financing activities, including the requirement for principal payments on the Company’s outstanding indebtedness.

See reconciliations of these non-GAAP measures to the most directly comparable GAAP measures included in the financial tables of this release.

Net Operating Loss Carryforwards

The Company’s Restated Certificate of Incorporation (the “Protective Amendment”) and Amended Tax Benefits Preservation Plan (the “Tax Plan”) includes provisions designed to protect the tax benefits of the Company’s net operating loss carryforwards by preventing certain transfers of our securities that could result in an “ownership change” (as defined under Section 382 of the Internal Revenue Code). The Protective Amendment generally restricts any direct or indirect transfer if the effect would be to (i) increase the direct, indirect or constructive ownership of any stockholder from less than 4.99 percent to 4.99 percent or more of the shares of common stock then outstanding or (ii) increase the direct, indirect or constructive ownership of any stockholder owning or deemed to own 4.99 percent or more of the shares of common stock then outstanding. Pursuant to the Protective Amendment, any direct or indirect transfer attempted in violation of the Protective Amendment would be void as of the date of the prohibited transfer as to the purported transferee (or, in the case of an indirect transfer, the ownership of the direct owner of the shares would terminate simultaneously with the transfer), and the purported transferee (or in the case of any indirect transfer, the direct owner) would not be recognized as the owner of the shares owned in violation of the Protective Amendment (the “excess stock”) for any purpose, including for purposes of voting and receiving dividends or other distributions in respect of such shares, or in the case of options, receiving shares in respect of their exercise. Pursuant to the Tax Plan and subject to certain exceptions, if a stockholder (or group) becomes a 4.99-percent stockholder after adoption of the Tax Plan, certain rights attached to each outstanding share of our common stock would generally become exercisable and entitle stockholders (other than the new 4.99-percent stockholder or group) to purchase additional shares of the Company at a significant discount, resulting in substantial dilution in the economic interest and voting power of the new 4.99-percent stockholder (or group). In addition, under certain circumstances in which the Company is acquired in a merger or other business combination after an non-exempt stockholder (or group) becomes a new 4.99-percent stockholder, each holder of a right (other than the new 4.99-percent stockholder or group) would then be entitled to purchase shares of the acquiring company’s common stock at a discount. For further discussion of the Company’s tax benefits preservation plan, please see the Company’s filings with the SEC.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are not historical facts are hereby identified as “forward-looking statements” for the purpose of the safe harbor provided by Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact, including without limitation, those with respect to the Company’s goals, plans, expectations and strategies set forth herein are forward-looking statements. The following important factors and uncertainties, among others, could cause actual results to differ materially from those described in these forward-looking statements: changes in the Company’s relationships with significant clients; fluctuations in demand for our products and services; the Company’s ability to achieve and sustain operating profitability; demand variability from clients without minimum purchase requirements; general economic conditions and public health crises (such as the ongoing COVID-19 pandemic); intense competition in the Company’s business; risks relating to impairment, misappropriation, theft and credit-related issues with respect to funds held for the Company’s clients; our ability to maintain adequate inventory levels; our ability to raise or access capital in the future; difficulties increasing operating efficiencies and effecting cost savings; loss of essential employees or an inability to recruit and retain personnel; the Company’s ability to execute on its business strategy and to achieve anticipated synergies and benefits from business acquisitions; risks inherent with conducting international operations, including the Company’s operations in Mainland China; the risk of damage, misappropriation or loss of the physical or intellectual property of the Company’s clients; increased competition and technological changes in the markets in which the Company competes; disruptions in or breaches of the Company’s technology systems; failure to settle disputes and litigation on terms favorable to the Company; challenges and risks arising from the disposition of IWCO Direct, including the Company’s reliance on the Supply Chain segment as its sole business; the Company’s ability to preserve and monetize its net operating losses; changes in tax rates, laws or regulations; failure to maintain compliance with Nasdaq’s continued listing requirements; potential conflicts of interest arising from the interests of the members of the Company’s board of directors in Steel Holdings and its affiliates; potential restrictions imposed by its indebtedness; and potential adverse effects from changes in interest rates and the phase-out of LIBOR. For a detailed discussion of cautionary statements and risks that may affect the Company’s future results of operations and financial results, please refer to the Company’s filings with the SEC, including, but not limited to, the risk factors in the Company’s Annual Report on Form 10-K filed with the SEC on October 31, 2022. These filings are available on the Company’s Investor Relations website under the “SEC Filings” tab.

All forward-looking statements are necessarily only estimates of future results, and there can be no assurance that actual results will not differ materially from expectations, and, therefore, you are cautioned not to place undue reliance on such statements. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events.

Investor Relations

Jennifer Golembeske

914-461-1276

[email protected]

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Supply Chain Management Retail

MEDIA:

Logo
Logo

Climate Change Investment Initiative Paves the Way for Innovation in Philadelphia

Climate Change Investment Initiative Paves the Way for Innovation in Philadelphia

Startups Can Apply Now Through September 15 to Receive Hundreds of Thousands of Dollars from the Exelon Foundation to Pursue Inventive Climate Solutions

CHICAGO–(BUSINESS WIRE)–
Startups whose products, services or technologies are focused on fighting climate change, and improving the quality of life for residents of the Philadelphia region and beyond, are encouraged to apply for an equity investment from 2c2i (Climate Change Investment Initiative), a joint effort of the Exelon Foundation and Exelon Corporation (Nasdaq: EXC).

Each year, Exelon provides equity investments to startups whose work benefits residents of a region served by the company. In addition to the Exelon Foundation’s $10 million financial investment over a 10-year period, Exelon Corporation invests up to $10 million of in-kind support, including mentoring entrepreneurs on ways to access other sources of capital, structure business plans, allocate financial resources and meet regulatory requirements. In the last two years alone, 2c2i companies have gone on to raise more than $100M in follow-on investments, in turn making a measurable impact on their communities.

“Climate change requires us to take bold, collective action,” said Sunny Elebua, Exelon’s Chief Strategy and Sustainability Officer. “The 2c2i program is a key component of Exelon’s commitment to addressing climate change in the communities most affected, which are often also the most underserved. This program supports community-based companies that are developing solutions and creating long-term economic opportunities, improving the quality of life for thousands. We’re looking forward to partnering with even more innovators with the zeal to have a lasting impact on generations to come.”

To qualify for 2c2i consideration, startups must be doing work that will benefit one or more of Exelon’s six major markets – Atlantic City, Baltimore, Chicago, Philadelphia, Washington, D.C., and Wilmington, Del. Their work must have the potential to do one of the following:

  • Mitigate greenhouse gas emissions

  • Boost the resiliency of urban infrastructure (e.g., the power grid, transportation systems, buildings, vacant land) against flood, stormwater and rising temperatures

  • Help cities, businesses and communities adapt to climate change; or

  • Help achieve a state or city’s specific sustainability and climate goals

Startups with innovative climate change solutions looking for investment should apply here now through September 15.

Recent recipients of a 2c2i investment currently creating an impact in their communities include Philadelphia-based Lula, a company providing rapid delivery technology to store owners to help them reach more customers and develop additional sales channels for growth.

The following companies were selected to receive investments for 2023:

Aclima

Aclima is pioneering an entirely new way to diagnose the health of our air and track climate-changing pollution. Their professional analytics software, Aclima Pro, translates the billions of scientific measurements of air pollution, greenhouse gases, and air toxics captured by Aclima’s mobile mapping network into environmental intelligence for governments, companies, and communities. Aclima is a purpose-driven technology company catalyzing bold climate action that protects public health, reduces emissions, and delivers clean air for all.

Byfusion

A company that utilizes a zero-waste carbon-neutral platform to repurpose non-recyclable plastic waste into an award-winning construction-grade alternative building material to help clean up the planet and revitalize neighborhoods everywhere.

Perl Street

Clean and distributed physical infrastructure assets require new financial asset managers to scale. Perl Street enables climate tech companies to offer financing programs and become asset managers. Their financial asset management software significantly reduces soft costs and overheads and unlocks the growth of distributed assets such as energy storage, electric vehicle charging stations, smart HVAC systems, and more.

Voltpost

With the mission to decarbonize mobility by democratizing charging access, Voltpost retrofits lampposts into a modular and upgradable electric vehicle charging platform. The Voltpost platform is scalable, reliable, and equitable to accelerate electric mobility adoption and exceed climate targets.

Sparkcharge

The first company to create a mobile EV charging system and network, was founded in part to expedite EV adoption and accessibility for everyone. Its mobile Charging-as-a-Service (CaaS) solutions enable businesses that operate EV fleets and consumers to have energy delivered directly to their EVs, where and when they need a charge.

About 2c2i

Launched in 2019, 2c2i (Climate Change Investment Initiative) combines the social and environmental impact objectives of the Exelon Foundation with the investment objectives and approach of venture capital. Over the past four year, 2c2i has invested in 32 companies, with 64% of the portfolio being minority or women-led and 57% of the portfolio being headquartered in Exelon’s footprint. Thus far the 2c2i portfolio has created more than 300 jobs and reduced, displaced, or avoided over 25,000 metric tons of GHG emissions through innovative solutions.

For more information on the 2c2i program, including previous investees and their continued impact, visitexelonfoundation.org/environment

The Exelon Foundation would like to recognize Katten, 2023 law firm sponsor, for providing in-kind legal services in support of the 2c2i program climate investments.

About Exelon

Exelon (Nasdaq: EXC) is a Fortune 200 company and the nation’s largest utility company, serving more than 10 million customers through six fully regulated transmission and distribution utilities — Atlantic City Electric (ACE), Baltimore Gas and Electric (BGE), Commonwealth Edison (ComEd), Delmarva Power & Light (DPL), PECO Energy Company (PECO), and Potomac Electric Power Company (Pepco). More than 18,000 Exelon employees dedicate their time and expertise to supporting our communities through reliable, affordable and efficient energy delivery, workforce development, equity, economic development and volunteerism. Follow Exelon on Twitter @Exelon

About the Exelon Foundation

The Exelon Foundation is an independent, nonprofit organization funded solely by Exelon Corporation through shareholder dollars. The mission of the Foundation is to encourage respect for the environment, support innovative STEM education programs and strengthen the social and economic fabric of the community by providing a match to Exelon employee contributions.

Rhea Marshall

312-394-7417 Media Hotline

[email protected]

KEYWORDS: United States North America Illinois Maryland Pennsylvania

INDUSTRY KEYWORDS: Other Energy Professional Services Utilities Sustainability Start-Up Socially Responsible Investing Energy Environment Other Professional Services Finance Climate Change Environmental, Social and Governance (ESG)

MEDIA:

Logo
Logo

Inspirato to Participate at the 2023 Cantor Fitzgerald Technology Conference

DENVER, June 12, 2023 (GLOBE NEWSWIRE) — Inspirato Incorporated (“Inspirato” or the “Company”) (NASDAQ: ISPO), the innovative luxury travel subscription brand, today announced its Chief Strategy Officer, Web Neighbor, will participate in a panel discussion, Travel Made Easy: A Discussion on the Landscape of the Travel Tech Space, at the 2023 Cantor Fitzgerald Technology Conference, and will be hosting investor meetings throughout the day:

2023 Cantor Fitzgerald Technology Conference
Panel Discussion: Travel Made Easy: A Discussion on the Landscape of the Travel Tech Space
10:30am ET, Thursday, June 15, 2023
@Ease Hospitality
605 E. 3rd Avenue
New York, New York

About Inspirato

Inspirato (NASDAQ: ISPO) is a luxury travel subscription company that provides exclusive access to a managed and controlled portfolio of curated vacation options, delivered through an innovative model designed to ensure the service, certainty, and value that discerning customers demand. The Inspirato portfolio includes branded luxury vacation homes, accommodations at five-star hotel and resort partners, and custom travel experiences. For more information, visit www.inspirato.com and follow @inspirato on Instagram, Facebook, Twitter, and LinkedIn.    

Contacts

Investor Relations   
[email protected]     

Media Relations  
[email protected]   

 



Oportun to Participate in Upcoming Investor Conferences

SAN CARLOS, Calif., June 12, 2023 (GLOBE NEWSWIRE) — Oportun (Nasdaq: OPRT), a mission-driven fintech, today announced that it will participate in the upcoming Sidoti Small Cap Conference and the 13th Annual East Coast IDEAS Investor Conference.

Oportun’s Chief Executive Officer, Raul Vazquez, and Chief Financial Officer & Chief Administrative Officer, Jonathan Coblentz, will present and participate in investor meetings at the conferences.  Details for the conference appearances are as follows:

Sidoti Small Cap Conference

Oportun will participate in investor meetings on June 14th and 15th and will be conducting an investor presentation. The presentation will begin at 4:00 PM EDT on June 14th and can be accessed live at this link.

13

th

Annual East Coast IDEAS Investor Conference

Oportun will participate in investor meetings on June 21st and 22nd and will be conducting an investor presentation. The presentation is scheduled to be available at 6:00 AM EDT on June 21st and can be accessed at this link.

Links to the presentation webcasts will also be accessible in the “IR calendar” section of Oportun’s Investor Relations website under “News & events” at https://investor.oportun.com. Replays will be accessible for an additional 90 days via the same links following the conferences.

About Oportun 
Oportun (Nasdaq: OPRT) is a mission-driven fintech that puts its 1.9 million members’ financial goals within reach. With intelligent borrowing, savings, budgeting, and spending capabilities, Oportun empowers members with the confidence to build a better financial future. Since inception, Oportun has provided more than $16.0 billion in responsible and affordable credit, saved its members more than $2.4 billion in interest and fees, and helped our members save an average of more than $1,800 annually. For more information, visit Oportun.com.

Investor Contact

Dorian Hare
(650) 590-4323
[email protected]

Media Contact

Usher Lieberman
(650) 769-9414
[email protected]



Brera Holdings PLC Names Pierre Galoppi CEO

International Executive to Lead Brera’s Global Brand Expansion

MILAN and DUBLIN, June 12, 2023 (GLOBE NEWSWIRE) — Brera Holdings PLC (the “Company,” “Brera” or “Brera Holdings”) (Nasdaq: BREA) has named Pierre Galoppi as its Chief Executive Officer.  Mr. Galoppi is a seasoned international executive and will lead Brera and its iconic brand as it pursues its international emerging sports brand expansion strategy.  “I am extremely pleased to be selected as the CEO of Brera Holdings during such an important period of growth and diversification across geographies and sports,” said Mr. Galoppi. 

Following its January 2023 initial public offering on the Nasdaq Stock Market, where Brera became the first Nasdaq-listed owner and manager of an Italian football club, Brera FC, known as “The Third Team of Milan,” Brera Holdings acquired the controlling interest in a first-division football team in North Macedonia in April 2023, and established a second-division squad in Mozambique in March 2023. In June 2023, Brera acquired a stake in Manchester United PLC (“MANU”) and invited the MANU board to a briefing on Brera’s innovative “Social Impact Football” business model and other value-building strategies. In May 2023, Brera announced that it plans to expand its acquisition strategy to include other team and individual sports in addition to football, which will remain its core business.

Pierre Galoppi has more than thirty years of experience with strategic business and financial services across a number of industries in the mid-level capital markets segment, including natural resources, aviation, cybersecurity, telecommunications, tourism, and international marketing. Mr. Galoppi’s transactional experience extends to Latin America, the Caribbean, Canada, Europe, and the United States.  Mr. Galoppi was born and raised in Rome, Italy, and is a dual citizen of Canada and Italy.  Mr. Galoppi is fluent in English, Spanish, Portuguese, Italian, and French.

“Throughout his career, Pierre has focused on cross-border and cross-cultural transactions and companies,” said Brera Holdings Executive Chairman Dan McClory. “His mergers and acquisitions experience will be of significant value to our international brand expansion strategy.  Brera has already demonstrated its ability to identify, approach and close international transactions,” Mr. McClory continued.  “We believe that Pierre’s skills and relationships in Latin America, Europe and North America can potentially bring additional dimensions to the Brera equity story and operations,” he concluded. Mr. Galoppi’s appointment is effective as of 4:00 P.M. Eastern Time on June 12, 2023, and he will also serve as the Interim Chief Financial Officer of Brera Holdings.

Since February 2007, Mr. Galoppi has served as the Managing Director of 1st PMG Capital Corporation, which provides consulting services in the areas of capital markets entry, fundraising, strategic partnerships, mergers and acquisitions and financial services. Through 1st PMG Capital Corporation, Mr. Galoppi has worked with a number of companies in the preparation of U.S. Securities and Exchange Commission (“SEC”) registration statements, as well as the filings associated with their public listing requirements.  Mr. Galoppi earned a Bachelor of Commerce degree and a Master of Business Administration degree from Concordia University in Montreal, Canada.

ABOUT BRERA HOLDINGS PLC

Brera Holdings PLC (Nasdaq: BREA) is focused on expanding on its social impact football (American soccer) business by developing a global portfolio of emerging football and other sports clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football- and sports-related consulting services. The Company seeks to build on the legacy and brand of Brera FC, the first football club that was acquired by the Company in 2022. Brera FC, known as “The Third Team of Milan,” is an amateur football association which has been building an alternative football legacy since its founding in 2000. In March 2023, the Company expanded to Africa with the establishment of Brera Tchumene, a team admitted to the Second Division Championship in Mozambique, a country of nearly 32 million people. In April 2023, the Company completed its 90%-acquisition of the European first division football team Fudbalski Klub Akademija Pandev in North Macedonia, a country with participation rights in two major Union of European Football Associations competitions. The Company is focused on bottom-up value creation from sports clubs and talent outside mainstream markets, innovation-powered business growth, and socially-impactful outcomes. See www.breraholdings.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company’s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company’s ability to continue as a going concern, the popularity and/or competitive success of the Company’s acquired football and other sports teams, the Company’s ability to attract players and staff for acquired clubs, unsuccessful acquisitions or other strategic transactions, the possibility of a decline in the popularity of football or other sports, the Company’s ability to expand its fanbase, sponsors and commercial partners, general economic conditions, and other risk factors detailed in the Company’s filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.

CONTACT INFORMATION:

Pierre Galoppi, Chief Executive Officer

Brera Holdings PLC


[email protected]

Daniel McClory, Executive Chairman

Brera Holdings PLC


[email protected]



Columbus McKinnon Publishes Third Annual Corporate Sustainability Report

Columbus McKinnon Publishes Third Annual Corporate Sustainability Report

BUFFALO, N.Y.–(BUSINESS WIRE)–Columbus McKinnon Corporation (Nasdaq: CMCO), a leading designer and manufacturer of intelligent motion solutions for material handling, today announced the publication of its third annual Corporate Sustainability (CSR) Report. This 2023 report details key initiatives in the areas of environmental sustainability, social impact, and governance responsibility, further illustrating Columbus McKinnon’s resilience and agility in delivering for its customers, while conducting business in a responsible manner.

Key achievements outlined in the Company’s annual CSR report include:

  • Listed as one of Newsweek Magazine’s “Top Responsible Companies” and received an excellent score of “B-“ as a first-time reporter to the Carbon Disclosure Project (CDP).

  • In addition to reporting to CDP, made first time disclosures aligned with the Taskforce on Carbon-Related Financial Disclosures’ (TCFD) standard in Fiscal Year 2023.

  • Launched CMCO Cares Program in Fiscal Year 2023, formalizing the Company’s corporate giving program

  • Launched Learning in Motion program to further employee development providing four tailored levels to address varying levels of professional experience

  • Advanced environmental transparency, socially impactful initiatives, and strong ethics and governance practices

  • Made measurable progress on waste reduction and energy management goals

“We are making great progress on many fronts as we build a stronger, sustainable enterprise and continue to further unlock our potential,” said David Wilson, President and CEO of Columbus McKinnon. “Sustainability and ESG are integrated throughout our business, our strategy, and our daily work. As we advance our efforts, we further reinforce the foundation from which we can continue to build. For us, ESG is embedded in our Purpose as we create intelligent motion solutions that move the world forward and improve lives.”

About Columbus McKinnon

Columbus McKinnon is a leading worldwide designer, manufacturer and marketer of intelligent motion solutions that move the world forward and improve lives by efficiently and ergonomically moving, lifting, positioning, and securing materials. Key products include hoists, crane components, precision conveyor systems, rigging tools, light rail workstations and digital power and motion control systems. The Company is focused on commercial and industrial applications that require the safety and quality provided by its superior design and engineering know-how. Comprehensive information on Columbus McKinnon is available at www.cmco.com.

Safe Harbor Statement

This news release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements concerning expected growth, sustainability and future potential to deliver results; the execution of its strategy and further transformation of the Company and achievement of certain goals. These statements involve known and unknown risks, uncertainties and other factors that could cause the actual results of the Company to differ materially from the results expressed or implied by such statements, including the ability of the Company to scale the organization, global economic and business conditions affecting the industries served by the Company and its subsidiaries including COVID-19; the Company’s customers and suppliers, competitor responses to the Company’s products and services, the overall market acceptance of such products and services, the ability to expand into new markets and geographic regions, and other factors disclosed in the Company’s periodic reports filed with the Securities and Exchange Commission. Consequently, such forward-looking statements should be regarded as current plans, estimates and beliefs. The Company assumes no obligation to update the forward-looking information contained in this release.

Gregory P. Rustowicz

Executive Vice President – Finance and Chief Financial Officer

Columbus McKinnon Corporation

716-689-5442

[email protected]

Investor Relations:

Deborah K. Pawlowski

Kei Advisors LLC

716-843-3908

[email protected]

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Technology Machinery Commercial Building & Real Estate Machine Tools, Metalworking & Metallurgy Construction & Property Trucking Steel Rail Engineering Transport Automotive Manufacturing Aerospace Manufacturing Sustainability Building Systems Environment Electronic Design Automation

MEDIA:

Logo
Logo

Orion to Attend the Wells Fargo Industrials Conference

Orion to Attend the Wells Fargo Industrials Conference

HOUSTON–(BUSINESS WIRE)–Orion S.A.(NYSE: OEC), a specialty chemical company, today announced that members of its executive management team will attend the Wells Fargo Industrials Conference in Chicago on Thursday, June 15, 2023.

Orion’s executives will be available to participate in one-on-one meetings with investors registered to attend the conference. As part of these meetings, the team will be updating current market conditions that may impact its second quarter 2023 volume expectations: for example, current prevailing trends affecting global truck replacement tire demand. The company does not provide quarterly guidance and is not revising its full year guidance at this point in time. An updated investor presentation can be found on the company’s website by clicking here.

About Orion S.A.

Orion S.A. (NYSE: OEC) is a leading global supplier of carbon black, a solid form of carbon produced as powder or pellets. The material is made to customers’ exacting specifications for tires, coatings, ink, batteries, plastics and numerous other specialty, high-performance applications. Carbon black is used to tint, colorize, provide reinforcement, conduct electricity, increase durability, and add UV protection. Orion has innovation centers on three continents and 15 plants worldwide, offering the most diverse variety of production processes in the industry. The company’s corporate lineage goes back more than 160 years to Germany, where it operates the world’s longest-running carbon black plant. Orion is a leading innovator, applying a deep understanding of customers’ needs to deliver sustainable solutions. For more information, please visit orioncarbons.com.

Forward-Looking Statements

This document contains certain forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements of future expectations that are based on current expectations and assumptions and involve known and unknown risks and uncertainties, including risks related to our planned payment of the interim dividend and the other risks and uncertainties listed under “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, each of which could cause actual results, performance, or events to differ materially from those expressed or implied in these statements. You should not place undue reliance on forward-looking statements. Each forward-looking statement speaks only as of the date of the particular statement. New risk factors and uncertainties emerge from time to time, and it is not possible to predict all risk factors and uncertainties, nor can we assess the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events, or other information, other than as required by applicable law.

Wendy Wilson

Orion

Head of Investor Relations

[email protected]

+1 281-974-0155

William Foreman

Orion

Director of Corporate Communications and Government Affairs

[email protected]

Direct: +1 832-445-3305

Mobile: +1 281-889-7833

KEYWORDS: United States North America Texas

INDUSTRY KEYWORDS: Trucking Chemicals/Plastics Automotive Transport Tires & Rubber Manufacturing

MEDIA:

Logo
Logo

Starton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma

Starton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma

  • FDA agrees to the planned Phase 1b study in second-line transplant-ineligible patients in multiple myeloma

  • Treatment regimen will include Velcade® (bortezomib) and dexamethasone and replace oral Revlimid® with STAR-LLD

PARAMUS, N.J.–(BUSINESS WIRE)–
Starton Therapeutics Inc. (“Starton” or “the Company”), a clinical stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, today provided updates on its Phase 1b STAR-LLD clinical trial of its investigational continuous delivery lenalidomide in multiple myeloma.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230612747752/en/

The U.S. Food and Drug Administration (“FDA”) notified the Company that it may proceed with the U.S.-based program in second-line transplant-ineligible patients using the combination of STAR-LLD, Velcade, and dexamethasone. This treatment paradigm will replace oral Revlimid with STAR-LLD. The planned study that follows this development will evaluate six patients for tolerability, immune biomarkers, and signals of efficacy of continuously delivered lenalidomide at the highest planned daily dose. The study is expected to accrue six patients in the United States in three to four centers over a period of 10 months and will provide readouts in the tolerability of the regimen, the impact of continuous delivery on immune function by measuring biomarkers of T-cell, NK-cell, and B-cell upregulation, and cytokine production induced by lenalidomide. It will also provide signals of efficacy in assessing response rates, duration of response, progression free survival, and changes in minimal residual disease.

Pedro Lichtinger, chairman and CEO of Starton Therapeutics commented, “Today’s announcement marks a significant development for Starton and patients in need of approved drugs and improved quality of life, and we are excited to begin this critical program in transplant-ineligible patients with multiple myeloma. This study will provide initial evidence of the impact of continuous delivery of lenalidomide both in terms of safety and efficacy, as well as provide clarity for signals of improvement in patients outcomes.”

As part of the development plans, the FDA agreed to have a meeting to review the initial data on safety and activity from the study as an interim analysis, while patients continue treatment for efficacy endpoints. This interim review is aimed at helping develop the plans for the approval path forward with Phase 2 studies for multiple myeloma, as well as other malignancies where lenalidomide has shown activity but is not approved for the new indications planned for study.

Dr. Jamie Oliver, Starton’s chief medical officer noted, “We are very happy with the agreed protocol, which allows a quick read for the key safety and efficacy data which we will review with the FDA. The upcoming Phase 1b clinical study in multiple myeloma is on track to begin enrollment in Q4 2023. Treatment of second-line patients at our proposed optimal dose of continuous lenalidomide in combination with the proteasome inhibitor Velcade and dexamethasone allows us to demonstrate activity in an established standard of care regimen by replacing Revlimid with STAR-LLD.”

Starton has signed an agreement for a business combination with Healthwell Acquisition Corp. I (Nasdaq: HWEL) (“Healthwell”). Please see “Additional Information and Where to Find It” below for additional information related to the proposed business combination.

About STAR-LLD

STAR-LLD is a continuous delivery lenalidomide in development to expand and replace the standard of care for the most common blood cancers, multiple myeloma and chronic lymphocytic leukemia (CLL). A preclinical proof-of-concept study for STAR-LLD demonstrated that MM tumors caused by human myeloma cells grew 25-fold if untreated, five-fold when treated with daily lenalidomide and shrank by 80% with STAR-LLD. The study also showed 100% efficacy (overall response rate ORR) at 144 mcg/day continuous LLD and 20% tumor elimination vs. 0% ORR with active control with daily pulsatile once daily dosing. In addition, a Phase 1 bioavailability study in healthy men comparing STAR-LLD to Revlimid demonstrated the drug is well tolerated and is >93% bioavailable by the subcutaneous route. It was also observed that the Cmax is <90% lower than oral Revlimid. These data support the safety of the planned Phase 1 dose of 400 mcg/hr (9.6 mg a day) versus a standard 25 mg a day dose for Revlimid.

About Starton Therapeutics

A clinical-stage biotechnology platform company focused on transforming standard of care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to live better, longer. Starton’s proprietary transdermal technology is intended to increase efficacy of approved drugs, to make them more tolerable and expand their potential use. To learn more, visit www.startontx.com.

About Healthwell

Healthwell is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.

Additional Information and Where to Find It

In connection with the transactions contemplated by the business combination agreement, dated April 27, 2023 (as amended on May 15, 2023 and as many be further amended or supplemented from time to time, the “Business Combination Agreement,” and all of the transactions contemplated thereunder, the “Transaction”), by and among Starton, Healthwell, HWEL Holdings Corp., a Delaware corporation and wholly-owned subsidiary of Healthwell (“Pubco”), and other parties thereto, Pubco filed a registration statement on Form S-4 with the U.S. Securities and Exchange Commission (the “SEC”) on May 15, 2023 (as may be amended or supplemented from time to time, the “Registration Statement”), which includes a preliminary proxy statement and a prospectus in connection with the Transaction. STOCKHOLDERS OF HEALTHWELL ARE ADVISED TO READ THE PRELIMINARY PROXY STATEMENT, AND, WHEN AVAILABLE, ANY AMENDMENTS THERETO, THE DEFINITIVE PROXY STATEMENT, THE PROSPECTUS AND ALL OTHER RELEVANT DOCUMENTS FILED OR THAT WILL BE FILED WITH THE SEC IN CONNECTION WITH THE TRANSACTION AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. THIS DOCUMENT WILL NOT CONTAIN ALL THE INFORMATION THAT SHOULD BE CONSIDERED CONCERNING THE TRANSACTION. IT IS ALSO NOT INTENDED TO FORM THE BASIS OF ANY INVESTMENT DECISION OR ANY OTHER DECISION IN RESPECT OF THE TRANSACTION. When available, the definitive proxy statement and other relevant documents will be mailed to the stockholders of Healthwell as of a record date to be established for voting on the Transaction. Stockholders and other interested persons will also be able to obtain copies of the preliminary proxy statement, the definitive proxy statement, the Registration Statement and other documents filed the SEC that will be incorporated by reference therein, without charge, once available, at the SEC’s website at www.sec.gov. Healthwell’s stockholders will also be able to obtain a copy of such documents, without charge, by directing a request to: Healthwell Acquisition Corp., 1001 Green Bay Rd, #227 Winnetka, IL 60093; e-mail: [email protected].

Forward-Looking Statements

This communication contains forward-looking statements for purposes of the “safe harbor” provisions under the United States Private Securities Litigation Reform Act of 1995. Any statements other than statements of historical fact contained herein are forward-looking statements. Such forward-looking statements include, but are not limited to, expectations, hopes, beliefs, intentions, plans, prospects, financial results or strategies regarding Starton and the Transaction and the future held by the respective management teams of Healthwell or Starton, the anticipated benefits and the anticipated timing of the Transaction, future financial condition and performance of Starton and expected financial impacts of the Transaction (including future revenue, pro forma enterprise value and cash balance), the satisfaction of closing conditions to the Transaction, financing transactions, if any, related to the Transaction, the level of redemptions of Healthwell’s public stockholders and the products and markets and expected future performance and market opportunities of Starton. These forward-looking statements generally are identified by the words “anticipate,” “believe,” “could,” “expect,” “estimate,” “future,” “intend,” “may,” “might,” “strategy,” “opportunity,” “plan,” “project,” “possible,” “potential,” “project,” “predict,” “scales,” “representative of,” “valuation,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this communication, including, without limitation: (i) the risk that the Transaction may not be completed in a timely manner or at all, which may adversely affect the price of Healthwell’s securities; (ii) the risk that the Transaction may not be completed by Healthwell’s business combination deadline and the potential failure to obtain an extension of the business combination deadline if sought by Healthwell; (iii) the failure to satisfy the conditions to the consummation of the Transaction, including, among others, the condition that Healthwell has cash or cash equivalents of at least $15 million, and the requirement that the Business Combination Agreement and the transactions contemplated thereby be approved by the stockholders of each of Healthwell and Starton; (iv) the failure to obtain any applicable regulatory approvals required to consummate the Transaction; (v) the occurrence of any event, change or other circumstance that could give rise to the termination of the Merger Agreement; (vi) the effect of the announcement or pendency of the Transaction on Starton’s business relationships, operating results, and business generally; (vii) risks that the Transaction disrupts current plans and operations of Starton; (viii) the risk that Pubco may not be able to raise funds in a PIPE financing or may not be able to raise as much as anticipated; (ix) the outcome of any legal proceedings that may be instituted against Starton or Healthwell related to the Business Combination Agreement or the Transaction; (x) the ability to maintain the listing of Healthwell’s securities on a national securities exchange or failure of Pubco to meet initial listing standards in connection with the consummation of the Transaction; (xi) uncertainty regarding outcomes of Starton’s ongoing clinical trials, particularly as they relate to regulatory review and potential approval for its product candidates; (xii) risks associated with Starton’s efforts to commercialize a product candidate; (xiii) Starton’s ability to negotiate and enter into definitive agreements for supply, sales, marketing, and/or distribution on favorable terms, if at all; (xiv) the impact of competing product candidates on Starton’s business; (xv) intellectual property-related claims; and (xvi) Starton’s ability to attract and retain qualified personnel; and (xvii) Starton’s ability to continue to source the raw materials for its product candidates.

The foregoing list of factors is not exhaustive. Recipients should carefully consider such factors and the other risks and uncertainties described and to be described in the “Risk Factors” section of Healthwell’s initial public offering (the “IPO”) prospectus filed with the SEC on August 4, 2021, Healthwell’s Annual Report on Form 10-K filed for the year ended December 31, 2022 filed with the SEC on March 3, 2023 and subsequent periodic reports filed by Healthwell with the SEC, the Registration Statement and other documents filed or to be filed by Healthwell and Pubco from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Recipients are cautioned not to put undue reliance on forward-looking statements, and neither Starton, Healthwell nor Pubco assume any obligation to, nor intend to, update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. Neither Starton, Healthwell nor Pubco gives any assurance that either Starton or Healthwell, or the combined company, will achieve its expectations.

Information Sources; No Representations

The information herein does not purport to be all-inclusive. The information herein is derived from various internal and external sources, with all information relating to the business, past performance, results of operations and financial condition of Healthwell derived entirely from Healthwell and all information relating to the business, past performance, results of operations and financial condition of Starton derived entirely from Starton. No representation is made as to the reasonableness of the assumptions made with respect to the information therein, or to the accuracy or completeness of any projections or modeling or any other information contained therein. Any data on past performance or modeling contained therein is not an indication as to future performance.

No representations or warranties, express or implied, are given in respect of the communication. To the fullest extent permitted by law in no circumstances will Healthwell, Starton or Pubco, or any of their respective subsidiaries, affiliates, shareholders, representatives, partners, directors, officers, employees, advisors or agents, be responsible or liable for any direct, indirect or consequential loss or loss of profit arising from the use of this communication (including without limitation any projections or models), any omissions, reliance on information contained within it, or on opinions communicated in relation thereto or otherwise arising in connection therewith, which information relating in any way to the operations of Starton has been derived, directly or indirectly, exclusively from Starton and has not been independently verified by Healthwell. Neither the independent auditors of Healthwell nor the independent auditors of or Starton audited, reviewed, compiled or performed any procedures with respect to any projections or models for the purpose of their inclusion in the communication and, accordingly, neither of them expressed any opinion or provided any other form of assurances with respect thereto for the purposes of the communication.

Prior Disclosures

Starton is aware that its CEO appeared on the television program “Unicorn Hunters” on June 7, 2021. During that appearance, the CEO made a number of representations as to Starton’s approach to reformulating drug products to improve efficacy, tolerability and patients’ quality of life. As part of these representations, the CEO raised the specific example of Starton’s investigational reformulation of Revlimid. While Starton believes in the value of its product, it understands that any clinical superiority claims cannot be made absent specific findings from rigorous clinical studies which Starton has not undertaken. The CEO’s comments on the television program were not intended to suggest Starton has conducted such studies; Starton does not have data to support these specific representations and disclaims any representations or purported representations by its CEO which either stated or implied the contrary.

Trademarks and Tradenames

This communication includes trademarks of Starton, which are protected under applicable intellectual property laws and are the property of Starton or its subsidiaries. This communication also includes other trademarks, trade names and service marks that are the property of their respective owners. We do not intend our use or display of other companies’ trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other companies.

Participants in the Solicitation

Healthwell, Starton, Pubco and their respective directors and executive officers may be deemed participants in the solicitation of proxies of Healthwell’s stockholders in connection with the Transaction. Healthwell’s stockholders and other interested persons may obtain more detailed information regarding the names, affiliations, and interests of certain of Healthwell executive officers and directors in the solicitation by reading Healthwell’s final prospectus filed with the SEC on August 4, 2021 in connection with the IPO, Healthwell’s Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on March 3, 2023 and Healthwell’s other filings with the SEC. A list of the names of such directors and executive officers and information regarding their interests in the Transaction, which may, in some cases, be different from those of stockholders generally, are set forth in the Registration Statement relating to the Transaction. These documents can be obtained free of charge from the source indicated above.

No Offer or Solicitation

This communication shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Transaction. This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption therefrom.

Starton Therapeutics

[email protected]

Healthwell

[email protected]

KEYWORDS: United States North America New Jersey

INDUSTRY KEYWORDS: Research FDA Clinical Trials Cardiology Biotechnology Health Pharmaceutical Science Oncology

MEDIA:

Logo
Logo
Logo
Logo

AAMC Issues Statement Regarding JPMorgan Chase Settlement Involving Jeffrey Epstein

AAMC Issues Statement Regarding JPMorgan Chase Settlement Involving Jeffrey Epstein

CHRISTIANSTED, U.S. Virgin Islands–(BUSINESS WIRE)–
In light of today’s litigation settlement by JPMorgan Chase & Co. and given that AAMC is based in the U.S. Virgin Islands, the company issued the following statement:

  • Altisource Asset Management Corporation (NYSE: AAMC) has had no known personal, financial or business interactions with the late Jeffrey Epstein, his estate, or business entities.

John P. de Jongh, Jr., former AAMC chairman, last week voluntarily resigned from the company’s board of directors. Due to de Jongh’s former position as governor of the U.S. Virgin Islands, he made the decision to resign as AAMC chairman to avoid any distractions from the operations of the company.

Please direct any media inquiries to [email protected].

About AAMC

AAMC is a private credit provider that originates alternative assets to provide liquidity and capital to under-served markets. We also continue to assess opportunities that could potentially be of long-term benefit to shareholders. Additional information is available at www.altisourceamc.com.

[email protected]

KEYWORDS: Virgin Islands (U.S.) Caribbean

INDUSTRY KEYWORDS: Asset Management Legal Professional Services Finance

MEDIA:

Logo
Logo